Furthermore, when the status of IGT plus T2DM were taken together into consideration as AbnGT, both postchallenge TNF-α (7.8 [7.4-9.0] versus 6.4 [4.5-7.3] pg/ml) and nitrotyrosine (1.02 [0.92-1.25] versus 0.81 [0.74-0.96] μmol/l) levels at 2-hr were still able to be demonstrated in AbnGT patients with or without CAD (both P values < 0.05) (Figure 3). The gene discussed is TNF; the disease is type 2 diabetes mellitus.